Company registration number 13538373 (England and Wales)
NUVO PHARMA LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
NUVO PHARMA LTD
COMPANY INFORMATION
Director
V Arena De Souza
Company number
13538373
Registered office
29 Shiplake Bottom
Peppard Common
Henley-On-Thames
England
RG9 5HH
Accountants
FLB Accountants LLP
1010 Eskdale Road
Winnersh Triangle
Wokingham
Berkshire
RG41 5TS
NUVO PHARMA LTD
CONTENTS
Page
Statement of financial position and notes to the financial statements
1 - 2
NUVO PHARMA LTD
STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2025
31 July 2025
- 1 -
2025
2024
£
£
£
£
Fixed assets
1,487
2,914
Current assets
48,286
30,530
Creditors: amounts falling due within one year
(21,403)
(31,402)
Net current assets/(liabilities)
26,883
(872)
Total assets less current liabilities
28,370
2,042
Accruals and deferred income
(1,500)
(1,500)
Net assets
26,870
542
Capital and reserves
26,870
542
Notes to the financial statements
1
Director's benefits: advances, credit and guarantees

At the balance sheet date, the director owed the company £18,724 (202 4: £nil). During the year £1 8,724 (202 4: £nil) was advanced and £nil (202 4: £nil) was repaid. Interest has been charged on this loan at HMRC's official rate. The loan is repayable on demand.

2
Employees

The average number of persons, including directors, employed by the company during the year wa s as follows:

2025
2024
Number
Number
Employees
0
1

Nuvo Pharma Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 29 Shiplake Bottom, Peppard Common, Henley-On-Thames, England, RG9 5HH.

For the year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

NUVO PHARMA LTD
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 JULY 2025
31 July 2025
- 2 -

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 15 April 2026
V Arena De Souza
Director
Company registration number 13538373 (England and Wales)
2025-07-31 2024-08-01 false false CCH Software CCH Accounts Production 2025.300 No description of principal activity V Arena De Souza false 13538373 2024-08-01 2025-07-31 13538373 bus:Director1 2024-08-01 2025-07-31 13538373 bus:RegisteredOffice 2024-08-01 2025-07-31 13538373 2025-07-31 13538373 2024-07-31 13538373 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 13538373 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 13538373 2023-08-01 2024-07-31 13538373 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 13538373 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 13538373 bus:Micro-entities 2024-08-01 2025-07-31 13538373 bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 13538373 bus:FullAccounts 2024-08-01 2025-07-31 xbrli:pure xbrli:shares iso4217:GBP